Published in Clin Med Insights Cardiol on January 07, 2015
Arterial Imaging of Inflammation and Resolution After Endovascular Surgery (AIIRES) | NCT03590769
Immunohistochemical Analysis of Cerebral Thrombi Retrieved by Mechanical Thrombectomy from Patients with Acute Ischemic Stroke. Int J Mol Sci (2016) 0.87
Imaging of atherosclerosis. Int J Cardiovasc Imaging (2015) 0.79
Design and baseline data from the Gratitude Research in Acute Coronary Events (GRACE) study. Contemp Clin Trials (2015) 0.79
Systems Biology and Noninvasive Imaging of Atherosclerosis. Arterioscler Thromb Vasc Biol (2016) 0.79
Dual-Modality Activity-Based Probes as Molecular Imaging Agents for Vascular Inflammation. J Nucl Med (2016) 0.75
Monocyte/lymphocyte ratio predicts the severity of coronary artery disease: a syntax score assessment. BMC Cardiovasc Disord (2017) 0.75
Elucidation of the Anti-Inflammatory Mechanisms of Bupleuri and Scutellariae Radix Using System Pharmacological Analyses. Mediators Inflamm (2017) 0.75
Inflammation, Atherosclerosis and Coronary Artery Disease. Clin Med Insights Cardiol (2016) 0.75
Feasibility of imaging superficial palmar arch using micro-ultrasound, 7T and 3T magnetic resonance imaging. World J Radiol (2017) 0.75
Inflammation and atherosclerosis. Circulation (2002) 20.77
Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J (1985) 5.83
Serial F-18-FDG PET/CT distinguishes inflamed from stable plaque phenotypes in shear-stress induced murine atherosclerosis. Atherosclerosis (2014) 5.19
Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol (2012) 4.52
Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation (2002) 4.43
Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat Med (2013) 4.14
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial. Lancet (2013) 4.03
In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol (2006) 3.91
Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology. J Am Coll Cardiol (2012) 3.03
PET imaging of inflammation in atherosclerosis. Nat Rev Cardiol (2014) 2.83
Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography. J Nucl Cardiol (2005) 2.65
Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations. J Nucl Med (2008) 2.52
Feasibility of FDG imaging of the coronary arteries: comparison between acute coronary syndrome and stable angina. JACC Cardiovasc Imaging (2010) 2.38
(18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. J Am Coll Cardiol (2007) 2.32
Metabolism of glucose, glutamine, long-chain fatty acids and ketone bodies by murine macrophages. Biochem J (1986) 2.21
18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease. J Nucl Med (2009) 2.19
New risk factors for atherosclerosis and patient risk assessment. Circulation (2004) 2.07
A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18): nontoxic tracer for rapid tumor detection. J Nucl Med (1980) 2.01
Imaging of vulnerable atherosclerotic plaques with FDG-microPET: no FDG accumulation. Atherosclerosis (2006) 1.92
Combining anatomy and function: the path to true image fusion. Eur Radiol (2001) 1.88
Brachial artery vasodilator function and systemic inflammation in the Framingham Offspring Study. Circulation (2004) 1.84
The biological role of inflammation in atherosclerosis. Can J Cardiol (2012) 1.77
Detection of neovessels in atherosclerotic plaques of rabbits using dynamic contrast enhanced MRI and 18F-FDG PET. Arterioscler Thromb Vasc Biol (2008) 1.73
Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study. Circ Cardiovasc Imaging (2009) 1.66
Gene expression and 18FDG uptake in atherosclerotic carotid plaques. Nucl Med Commun (2010) 1.57
Vascular inflammation evaluated by [18F]-fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome. J Am Coll Cardiol (2007) 1.53
Facilitative glucose transporter gene expression in human lymphocytes, monocytes, and macrophages: a role for GLUT isoforms 1, 3, and 5 in the immune response and foam cell formation. Blood Cells Mol Dis (2004) 1.52
Changing patterns of abnormal vascular wall F-18 fluorodeoxyglucose uptake on follow-up PET/CT studies. J Nucl Cardiol (2006) 1.51
Rates of utilization and fates of glucose, glutamine, pyruvate, fatty acids and ketone bodies by mouse macrophages. Biochem J (1987) 1.45
Molecular pathology in vulnerable carotid plaques: correlation with [18]-fluorodeoxyglucose positron emission tomography (FDG-PET). Eur J Vasc Endovasc Surg (2008) 1.38
Inflammation imaging in atherosclerosis. Arterioscler Thromb Vasc Biol (2009) 1.38
Quantification of inflammation within rabbit atherosclerotic plaques using the macrophage-specific CT contrast agent N1177: a comparison with 18F-FDG PET/CT and histology. J Nucl Med (2009) 1.31
Endothelial function. Circulation (2011) 1.31
Retracted Activated macrophages utilize glycolytic ATP to maintain mitochondrial membrane potential and prevent apoptotic cell death. Cell Death Differ (2010) 1.29
Molecular imaging of atherosclerosis for improving diagnostic and therapeutic development. Circ Res (2012) 1.29
F-18 FDG uptake in the large arteries: a new observation. Clin Nucl Med (2001) 1.28
Novel concepts in atherogenesis: angiogenesis and hypoxia in atherosclerosis. J Pathol (2009) 1.27
What is the natural history of 18F-FDG uptake in arterial atheroma on PET/CT? Implications for imaging the vulnerable plaque. Atherosclerosis (2010) 1.22
Expression, pharmacology, and functional role of somatostatin receptor subtypes 1 and 2 in human macrophages. J Leukoc Biol (2006) 1.22
Initial and subsequent approach for the synthesis of 18FDG. Semin Nucl Med (2002) 1.18
Evolving role of positron emission tomography in the management of patients with inflammatory and other benign disorders. Semin Nucl Med (2004) 1.16
Feasibility of simultaneous PET/MR of the carotid artery: first clinical experience and comparison to PET/CT. Am J Nucl Med Mol Imaging (2013) 1.15
Expression of somatostatin, cortistatin, and somatostatin receptors in human monocytes, macrophages, and dendritic cells. Am J Physiol Endocrinol Metab (2003) 1.15
Vascular inflammation in patients with impaired glucose tolerance and type 2 diabetes: analysis with 18F-fluorodeoxyglucose positron emission tomography. Circ Cardiovasc Imaging (2010) 1.15
Optimizing 18F-FDG PET/CT imaging of vessel wall inflammation: the impact of 18F-FDG circulation time, injected dose, uptake parameters, and fasting blood glucose levels. Eur J Nucl Med Mol Imaging (2013) 1.14
68Ga-DOTATATE PET/CT for the detection of inflammation of large arteries: correlation with18F-FDG, calcium burden and risk factors. EJNMMI Res (2012) 1.14
Bioenergetic profiles diverge during macrophage polarization: implications for the interpretation of 18F-FDG PET imaging of atherosclerosis. J Nucl Med (2013) 1.13
Characterization of signal properties in atherosclerotic plaque components by intravascular MRI. Arterioscler Thromb Vasc Biol (2000) 1.13
In vivo imaging of macrophage activity in the coronary arteries using 68Ga-DOTATATE PET/CT: correlation with coronary calcium burden and risk factors. J Nucl Med (2010) 1.11
Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet. AJR Am J Roentgenol (2008) 1.09
Somatostatin receptors 2 and 5 are preferentially expressed in proliferating endothelium. Br J Cancer (2005) 1.09
Detection of atherosclerosis using a novel positron-sensitive probe and 18-fluorodeoxyglucose (FDG). Nucl Med Commun (2001) 1.06
18F FDG uptake in the large arteries: a correlation study with the atherogenic risk factors. Semin Nucl Med (2002) 1.04
Association of inflammation of the left anterior descending coronary artery with cardiovascular risk factors, plaque burden and pericardial fat volume: a PET/CT study. Eur J Nucl Med Mol Imaging (2010) 1.02
What can be seen by 18F-FDG PET in atherosclerosis imaging? The effect of foam cell formation on 18F-FDG uptake to macrophages in vitro. J Nucl Med (2011) 1.02
The complementary roles of dynamic contrast-enhanced MRI and 18F-fluorodeoxyglucose PET/CT for imaging of carotid atherosclerosis. Eur J Nucl Med Mol Imaging (2013) 1.02
18FDG PET and ultrasound echolucency in carotid artery plaques. JACC Cardiovasc Imaging (2010) 1.02
Correlation between arterial FDG uptake and biomarkers in peripheral artery disease. JACC Cardiovasc Imaging (2012) 1.02
The advancing clinical impact of molecular imaging in CVD. JACC Cardiovasc Imaging (2013) 1.01
Characterization of plaques using 18F-FDG PET/CT in patients with carotid atherosclerosis and correlation with matrix metalloproteinase-1. J Nucl Med (2007) 1.00
Coronary arterial 18F-FDG uptake by fusion of PET and coronary CT angiography at sites of percutaneous stenting for acute myocardial infarction and stable coronary artery disease. J Nucl Med (2012) 0.99
18F-choline images murine atherosclerotic plaques ex vivo. Arterioscler Thromb Vasc Biol (2005) 0.97
Longitudinal effects of a decade of aging on carotid artery stiffness: the multiethnic study of atherosclerosis. Stroke (2013) 0.97
Granulocytes utilize different energy sources for movement and phagocytosis. Inflammation (1982) 0.95
Progression of carotid intima-media thickness as predictor of vascular events: results from the IMPROVE study. Arterioscler Thromb Vasc Biol (2013) 0.95
Monitoring plaque inflammation in atherosclerotic rabbits with an iron oxide (P904) and (18)F-FDG using a combined PET/MR scanner. Atherosclerosis (2013) 0.94
Quantification of atherosclerotic plaque activity and vascular inflammation using [18-F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT). J Vis Exp (2012) 0.93
One step closer to imaging vulnerable plaque in the coronary arteries. J Nucl Med (2009) 0.93
(18)F-FDG PET imaging of murine atherosclerosis: association with gene expression of key molecular markers. PLoS One (2012) 0.93
Genetic risk factors of atherothrombosis. Pol Arch Med Wewn (2014) 0.93
Evaluation of 18F-FDG uptake and arterial wall calcifications using 18F-FDG PET/CT. J Nucl Med (2004) 0.92
Evaluation and comparison of 11C-choline uptake and calcification in aortic and common carotid arterial walls with combined PET/CT. Eur J Nucl Med Mol Imaging (2009) 0.92
Inflammation and cardiovascular disease: from pathogenesis to therapeutic target. Curr Atheroscler Rep (2014) 0.91
Imaging of the carotid arteries: the role of duplex ultrasonography, magnetic resonance arteriography, and computerized tomographic arteriography. Vasc Med (2008) 0.90
Imaging of early inflammation in low-to-moderate carotid stenosis by 18-FDG-PET. Front Biosci (Landmark Ed) (2009) 0.90
Matrix-metalloproteinases as imaging targets for inflammatory activity in atherosclerotic plaques. J Nucl Med (2010) 0.90
Combined 18F-FDG PET-CT and DCE-MRI to assess inflammation and microvascularization in atherosclerotic plaques. Stroke (2013) 0.89
Specific somatostatin receptor II expression in arterial plaque: (68)Ga-DOTATATE autoradiographic, immunohistochemical and flow cytometric studies in apoE-deficient mice. Atherosclerosis (2013) 0.89
FDG PET imaging and cardiovascular inflammation. Curr Cardiol Rep (2011) 0.88
Impact of cardiovascular risk factors on vessel wall inflammation and calcified plaque burden differs across vascular beds: a PET-CT study. Int J Cardiovasc Imaging (2013) 0.88
Uptake of 11C-choline in mouse atherosclerotic plaques. J Nucl Med (2010) 0.87
Positron emission tomography imaging of atherosclerosis. Theranostics (2013) 0.87
Pre-clinical and clinical evaluation of nuclear tracers for the molecular imaging of vulnerable atherosclerosis: an overview. Curr Med Chem (2009) 0.86
Imaging of atherosclerotic aorta of rabbit model by detection of plaque inflammation with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography. Chin Med J (Engl) (2011) 0.85
Subclinical vascular inflammation in subjects with normal weight obesity and its association with body fat: an 18 F-FDG-PET/CT study. Cardiovasc Diabetol (2014) 0.85
Relation of carotid artery 18F-FDG uptake to C-reactive protein and Framingham risk score in a large cohort of asymptomatic adults. J Nucl Med (2013) 0.85
Influence of glucose metabolism on vascular smooth muscle cell proliferation. Vasa (2013) 0.83
Feasibility of 18F-fluoromethylcholine PET/CT for imaging of vessel wall alterations in humans--first results. Eur J Nucl Med Mol Imaging (2008) 0.83
Towards coronary plaque imaging using simultaneous PET-MR: a simulation study. Phys Med Biol (2014) 0.82
PET/MR imaging of atherosclerosis: initial experience and outlook. Am J Nucl Med Mol Imaging (2013) 0.82
Radiotracer imaging of atherosclerotic plaque biology. Cardiol Clin (2009) 0.81
Imaging of lower extremity artery atherosclerosis in diabetic foot: FDG-PET imaging and histopathological correlates. Clin Nucl Med (2007) 0.81
Retrospective study of coronary uptake of 18F-fluorodeoxyglucose in association with calcification and coronary artery disease: a preliminary study. Nucl Med Commun (2009) 0.81
Imaging of atherosclerosis: can molecular imaging do more? Arch Cardiovasc Dis (2013) 0.80
Non-FDG imaging of atherosclerosis: will imaging of MMPs assess plaque vulnerability? J Nucl Cardiol (2012) 0.79
Inter-study reproducibility of 3D volume selective fast spin echo sequence for quantifying carotid artery wall volume in asymptomatic subjects. Atherosclerosis (2005) 0.78
Clinical assessment of carotid atherosclerosis inflammation by positron emission tomography. Curr Mol Med (2013) 0.78
Positron emission tomography imaging for vascular inflammation evaluation in elderly subjects with different risk factors for cardiovascular diseases. Am J Nucl Med Mol Imaging (2014) 0.78
Carotid plaque inflammation in stroke assessed by PET: a burning issue? Neurology (2014) 0.78
Detection of vulnerable atherosclerotic plaque and prediction of thrombosis events in a rabbit model using 18F-FDG -PET/CT. PLoS One (2013) 0.78
Trained Immunity in Organ Transplantation. Am J Transplant (2019) 0.75